Evolent Health Inc Class A (EVH)
EBITDA Growth
-7.28%
Quarterly · Period ending:
EVH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-7.28%period ending
Latest reported-7.28%period ending
EVH Quarterly EBITDA YoY % (-39.13% → -7.28%)
Year-over-year change
High-resolution chart · PNG
EVH ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -7.2792% | |
| 147.49% | |
| -2,860.2995% | |
| 68.3982% | |
| -62.0831% | |
| -252.8081% | |
| 313.3772% | |
| -35.2979% | |
| 147.5308% | |
| 140.8361% | |
| -125.6561% | |
| 193.0316% | |
| 13.358% | |
| -448.5188% | |
| 0.6177% | |
| -335.8789% | |
| -25.6971% | |
| 18.8564% | |
| 168.6192% | |
| 158.383% | |
| 109.7184% | |
| 122.0582% | |
| 104.4629% | |
| -91.0452% | |
| -1,447.4633% | |
| -60.7561% | |
| -745,333.3333% | |
| -521.3169% | |
| -1,647.3965% | |
| -743.442% | |
| 100.4198% | |
| 80.5476% | |
| 105.9696% | |
| 75.5321% | |
| 76.825% | |
| 49.1616% | |
| -39.1483% | |
| 91.1479% | |
| -150.5326% | |
| 13.4179% | |
| 14.5713% | |
| -1,949.4157% | |
| -348.0581% | |
| 100% | |
| -39.126% |